Since we have shown that Bay11-7085 treatment of PEL cells causes down-regulation of NFκB and PI3-kinase/AKT pathway, we sought to determine whether these effects cause inhibition of cell viability and induce apoptosis in PEL cells. This evidence concerns the gene AKT1 and primary effusion lymphoma.